DALLAS-FORT WORTH, TX — April 2, 2025— BioStone Animal Health is pleased to announce the launch of the AsurDxTM Avian Influenza Virus H5/H7 (AIV-H5/H7) Real-Time PCR Detection Kit designed for the detection of H5 and H7 subtype of avian influenza virus RNA in tissue/throat swabs. The avian influenza virus subtypes are labeled according to an H number (for the type of hemagglutinin) and an N number (for the type of neuraminidase). There are 18 different known H antigens (H1 to H18) and 11 different known N antigens (N1 to N11).
This kit uses specific primers designed for the HA gene of avian influenza virus H5 and H7 subtypes, combined with specific fluorescent probes. Using one-step fluorescent RT-PCR technology, it amplifies and detects the RNA of H5 and H7 subtypes of avian influenza virus in vitro.
The AsurDxTM Avian Influenza Virus H5/H7 (AIV-H5/H7) Real-Time PCR Detection Kit is part of BioStone’s portfolio of single (e.g., H1-H10, N1-N4, and N6-N10), dual (e.g., H5N1, HXNY), triple (e.g., H5H7H9), quadruple (e.g., N1N2N6N8), and universal nucleic acid real-time PCR detection kits. Additionally, BioStone’s Influenza A Virus cELISA antibody test kits can detect antibodies specific to the H5, H7, or all subtypes of Influenza A Virus.
About BioStone Animal Health — BioStone Animal Health is a Dallas, TX-based biotechnology company that provides innovative solutions for animal health. BioStone Animal Health works together with our worldwide partners to offer a portfolio of animal disease diagnostic products as well as test kits and reagents for vaccine testing that enables performing a rapid evaluation of the efficacies, stability, consistency, and potency of common animal vaccines. By making these test kits available to the international community, BioStone strives to actively promote and participate in global animal health initiatives. For more information about BioStone Animal Health, visit www.biostoneah.com
